• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

102
39
24
24
20

COUNTRY

17
16
16
15
15

CATEGORIES

  • 265
  • 256
  • 78
  • 76
  • 63
  • 58
  • 53
  • 49
  • 48
  • 43
  • 35
  • 32
  • 22
  • 21
  • 16
  • 16
  • 16
  • 12
  • 12
  • 8
  • 6
  • 6
  • 6
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

113
175
828
1,025

PUBLISHED

4
96
449
1,025

PRODUCT TYPE

864
160
1

Search "Cell Therapeutics Inc.-Therapeutic Competitors" returned 1,025 results.

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

April 2015
FROM

Cell Therapeutics, Inc. (CTIC) - Financial and Strategic SWOT Analysis Review

Cell Therapeutics, Inc. (CTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Sickle Cell Disease - Pipeline Review, H2 2014

Sickle Cell Disease - Pipeline Review, H2 2014 Summary This, ‘Sickle Cell Disease - Pipeline Review, H2 2014’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This report...

October 2014
FROM

Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth

The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16 6 billion in 2012 to a projected value of $21 6 billion in 2019 This growth...

October 2013
FROM

Sickle Cell Disease - Pipeline Review, H1 2015

Sickle Cell Disease - Pipeline Review, H1 2015 Summary This, ‘Sickle Cell Disease - Pipeline Review, H1 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This report...

May 2015
FROM

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government...

November 2011
FROM

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014 Summary This, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014’, provides an overview...

December 2014
FROM

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

February 2015
FROM

Cell Therapeutics Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Cell Therapeutics Inc. Company Profile” is a comprehensive report on Cell Therapeutics Inc.. The report provides complete information on the operations, organization structure and financial information...

October 2014
FROM

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014’, provides an overview of the...

December 2014
FROM

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies The benefits of stem cell therapy are attracting an increasing number of patients The product...

November 2009
FROM

Small-Cell Lung Cancer - Pipeline Review, H2 2014

Small-Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Small-Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline. This...

July 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H1 2014

Small-Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic...

February 2014
FROM

Mantle Cell Lymphoma - Pipeline Review, H1 2015

Mantle Cell Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This report...

January 2015
FROM

Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014

Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014 Summary This, ‘Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014’, provides...

December 2014
FROM

Hairy Cell Leukemia - Pipeline Review, H1 2014

Hairy Cell Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H1 2014’, provides an overview of the Hairy Cell Leukemia’s therapeutic pipeline. This...

April 2014
FROM

Sickle Cell Disease - Pipeline Review, H1 2014

Sickle Cell Disease - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2014’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline. This...

April 2014
FROM

Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2014

Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Metastatic Renal Cell Carcinoma’s...

July 2014
FROM

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic...

July 2014
FROM

Ocata Therapeutics, Inc. (OCAT) - Financial and Strategic SWOT Analysis Review

Ocata Therapeutics, Inc. (OCAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

May 2015
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group